Cometriq 100 Mg Capsules

100mg Capsule , Box

4.5 (154)

25,500

Cometriq 100 mg Capsule contains Cabozantinib, a targeted anticancer medicine used to treat advanced medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma in eligible patients. It works by blocking multiple tyrosine kinase receptors involved in cancer cell growth, blood vessel formation, and tumor spread. This helps slow or stop the progression of cancer. Take Cometriq 100 mg Capsule exactly as prescribed by your doctor and attend regular follow-up appointments to monitor your response and manage possible side effects.

Description

Preface Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule is a tyrosine kinase asset used to treat advanced renal cell melanoma, hepatocellular melanoma, and medullary thyroid cancer.

Uses Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule is indicated for the treatment of progressive, metastatic medullary thyroid cancer. It’s also indicated for the treatment of advanced renal cell melanoma and for hepatocellular melanoma in cases preliminarily treated with sorafenib.

Medium Of Action Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule inhibits specific receptor tyrosine kinases similar as VEGFR- 1,-2 and-3, tackle, TRKB, FLT- 3, AXL, RET, MET, and TIE- 2.

Contact Us

Info Table
Manufacturer Exelixis
Prescription/Non prescription Prescription
Composition Cabozantinib 100 mg
Brand Cometriq 100 mg
Packaging Size 30 Capsule
Form Capsules
Treatment Medullary Thyroid Cancer
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Preface Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule is a tyrosine kinase asset used to treat advanced renal cell melanoma, hepatocellular melanoma, and medullary thyroid cancer.

Uses Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule is indicated for the treatment of progressive, metastatic medullary thyroid cancer. It’s also indicated for the treatment of advanced renal cell melanoma and for hepatocellular melanoma in cases preliminarily treated with sorafenib.

Medium Of Action Of Cometriq 100 Mg Capsule:

Cometriq 100 mg capsule inhibits specific receptor tyrosine kinases similar as VEGFR- 1,-2 and-3, tackle, TRKB, FLT- 3, AXL, RET, MET, and TIE- 2.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Cometriq 100 Mg Capsules”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Cometriq 100mg Capsule used for?
Cometriq 100mg Capsule contains Cabozantinib, a targeted cancer medicine used to treat advanced medullary thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer) in eligible patients.
No, that’s a common confusion — it treats carcinomas (renal cell and hepatocellular), not melanoma, which is a different type of cancer arising from skin pigment cells.
Take it once daily on an empty stomach, at least 1 hour before or 2 hours after eating, at the same time each day, exactly as prescribed.
Grapefruit and grapefruit juice can interfere with how the body processes this medication, potentially increasing side effects, so they should be avoided throughout treatment.
It works by blocking several tyrosine kinase receptors that cancer cells use to grow, form new blood vessels, and spread, which helps slow or stop cancer progression.
Cometriq 100mg Capsule contains Cabozantinib 100mg, manufactured by Exelixis, supplied as 30 capsules per box, made in India, and classified as a prescription-only targeted cancer medication.

Related products